Mallinckrodt Pharmaceuticals
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The company’s Autoimmune and Rare Diseases business includes H.P. Acthar® Gel (repository corticotropin injection), indicated for use in multiple specialties. Mallinckrodt’s other areas of focus include immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. To learn more about Acthar, visit Exhibit #1503 or www.Acthar.com. com.